Plasma Nitrate and Nitrite Changes During IL-2 Therapy
Author Information
Author(s): G Citteriol, F Pellegatta, G Di Lucca, G Fragasso, U Scaglietti, D Pinil, C Fortis, M Tresoldi, C Rugarlil
Primary Institution: IRCCS S. Raffaele, Milan, Italy
Hypothesis
The study aims to determine the pattern of plasma nitric oxide changes during continuous intravenous infusion of interleukin 2 and its correlation with cardiovascular side effects.
Conclusion
The study concludes that plasma nitrate and nitrite levels can estimate the degree of vascular relaxation and capillary leakage during IL-2 therapy, but do not predict cardiac toxicity.
Supporting Evidence
- Plasma nitrate and nitrite levels significantly increased during IL-2 treatment.
- A dose-dependent pattern of plasma nitrate and nitrite levels was observed.
- All patients experienced hypotension during the treatment.
- The mean systolic blood pressure was significantly lower at the time of plasma nitrate and nitrite peak.
Takeaway
This study looked at how a treatment for cancer affects certain chemicals in the blood that can cause low blood pressure, but it found that these chemicals don't explain heart problems that can happen with the treatment.
Methodology
Ten advanced cancer patients received continuous intravenous infusion of IL-2, and plasma samples were collected at various time points to measure nitrate and nitrite levels.
Limitations
The study does not establish a correlation between plasma nitrate and nitrite levels and cardiac toxicity.
Participant Demographics
Five males and five females, median age 59 years, with eight patients having renal cell cancer and two having malignant melanoma.
Statistical Information
P-Value
P=0.0226 for to vs t3; P=0.0329 for to vs t3; P=0.0354 for to vs t2 vs t4
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website